Functional Involvement of Serum Response Factor in the Transcriptional Regulation of Caldesmon Gene

1998 ◽  
Vol 242 (2) ◽  
pp. 429-435 ◽  
Author(s):  
Takuya Momiyama ◽  
Ken'ichiro Hayashi ◽  
Hideto Obata ◽  
Yoshihiro Chimori ◽  
Toshirou Nishida ◽  
...  
Keyword(s):  
Transcriptional Regulation ◽  
Serum Response Factor ◽  
Response Factor ◽  
Functional Involvement ◽  
Serum Response

scholarly journals Contribution of serum response factor and myocardin to transcriptional regulation of smoothelins

2006 ◽  
Vol 70 (1) ◽  
pp. 136-145 ◽  
Author(s):  
S RENSEN ◽  
P NIESSEN ◽  
X LONG ◽  
P DOEVENDANS ◽  
J MIANO ◽  
...  
Keyword(s):  
Transcriptional Regulation ◽  
Serum Response Factor ◽  
Response Factor ◽  
Serum Response

scholarly journals The Aging Vasculature: Glucose Tolerance, Hypoglycemia and the Role of the Serum Response Factor

2021 ◽  
Vol 8 (5) ◽  
pp. 58
Author(s):  
Hazel Aberdeen ◽  
Kaela Battles ◽  
Ariana Taylor ◽  
Jeranae Garner-Donald ◽  
Ana Davis-Wilson ◽  
...  
Keyword(s):  
Glucose Tolerance ◽  
Molecular Mechanisms ◽  
Serum Response Factor ◽  
Response Factor ◽  
Homeostatic Control ◽  
Older Americans ◽  
The Subject ◽  
Serum Response

The fastest growing demographic in the U.S. at the present time is those aged 65 years and older. Accompanying advancing age are a myriad of physiological changes in which reserve capacity is diminished and homeostatic control attenuates. One facet of homeostatic control lost with advancing age is glucose tolerance. Nowhere is this more accentuated than in the high proportion of older Americans who are diabetic. Coupled with advancing age, diabetes predisposes affected subjects to the onset and progression of cardiovascular disease (CVD). In the treatment of type 2 diabetes, hypoglycemic episodes are a frequent clinical manifestation, which often result in more severe pathological outcomes compared to those observed in cases of insulin resistance, including premature appearance of biomarkers of senescence. Unfortunately, molecular mechanisms of hypoglycemia remain unclear and the subject of much debate. In this review, the molecular basis of the aging vasculature (endothelium) and how glycemic flux drives the appearance of cardiovascular lesions and injury are discussed. Further, we review the potential role of the serum response factor (SRF) in driving glycemic flux-related cellular signaling through its association with various proteins.

Sign in / Sign up

Export Citation Format

Share Document